However, while CD207+ DCs were present in close relation to cancer cells, this was apparently not enough to induce a meaningful immunological response targeting cancer antigens, which would prevent NPC from occurring or to be killed off. The gene discussed is CD207; the disease is nasopharyngeal carcinoma.